Lung cancer is the leading cause of cancer death in men and women worldwide. Brain
metastasis (BMs) of non-small cell lung cancer (NSCLC) is the most important cause of …

Objectives The purpose of this study was to examine the impact of EGFR mutations on the
incidence of brain metastases in patients with advanced non-small cell lung cancer …

Background Lung cancer is the leading cause of cancer-related death worldwide. Numerous
studies have been performed to investigate the correlation between epidermal growth factor …

Introduction Epidermal growth factor receptor (EGFR) mutations in non–small-cell lung
cancers (NSCLC) may be more common in patients with brain metastases. Previous studies …

Previous studies have demonstrated the association between EGFR mutations and distant
metastasis. However, the association for subsequent brain metastasis (BM) in stages I-III …

Brain metastasis (BM) is a leading cause of death in patients with non-small cell lung cancer
(NSCLC). EGFR mutations in primary NSCLC lesions have been associated with sensitivity …

Background The brain is a frequent site of metastases from non-small-cell lung cancer
(NSCLC). We analyzed the frequency of brain metastases (BMs) from NSCLC in the era of …

A small subset of patients with nonsmall cell lung cancer (NSCLC) harbors mutations in the
epidermal growth factor receptor (EGFR) that predict unique sensitivity to EGFR tyrosine …

Brain metastases are a frequent and grave complication of non-small cell lung carcinoma
(NSCLC). The prognosis is generally poor, despite standard therapy based on surgery and …

Background: Brain metastases (BMs) is one of the most frequent metastatic sites for non-
small-cell lung cancer (NSCLC). It is a matter of debate whether EGFR mutation in the …